Definitive Healthcare Corp. (DH)
USD 3.92
(-5.08%)
USD 3.92
(-5.08%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 546.47 Million USD | -8.23% |
| 2022 | 213.4 Million USD | 48.03% |
| 2021 | 144.15 Million USD | 46.33% |
| 2020 | 98.51 Million USD | 120.68% |
| 2019 | 44.64 Million USD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q2 | 44.19 Million USD | -9.39% |
| 2024 Q1 | 48.77 Million USD | -5.73% |
| 2023 Q4 | 51.74 Million USD | -10.64% |
| 2023 FY | 195.83 Million USD | -8.23% |
| 2023 Q1 | 56.53 Million USD | -4.03% |
| 2023 Q2 | 58.28 Million USD | 3.1% |
| 2023 Q3 | 57.9 Million USD | -0.66% |
| 2022 Q2 | 51.87 Million USD | 7.03% |
| 2022 FY | 213.4 Million USD | 48.03% |
| 2022 Q1 | 48.47 Million USD | 8.6% |
| 2022 Q4 | 58.9 Million USD | 8.8% |
| 2022 Q3 | 54.14 Million USD | 4.37% |
| 2021 FY | 144.15 Million USD | 46.33% |
| 2021 Q4 | 44.63 Million USD | 21.41% |
| 2021 Q3 | 36.76 Million USD | 10.92% |
| 2021 Q2 | 33.14 Million USD | 11.9% |
| 2021 Q1 | 29.61 Million USD | 1.2% |
| 2020 Q3 | 23.56 Million USD | -15.68% |
| 2020 FY | 98.51 Million USD | 120.68% |
| 2020 Q1 | 27.94 Million USD | 0.0% |
| 2020 Q2 | 27.94 Million USD | 0.0% |
| 2020 Q4 | 29.26 Million USD | 24.23% |
| 2019 FY | 44.64 Million USD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Accolade, Inc. | 306.51 Million USD | -78.288% |
| Aclarion, Inc. | 4.87 Million USD | -11108.233% |
| Aclarion, Inc. | 4.87 Million USD | -11108.233% |
| Augmedix, Inc. | 40.3 Million USD | -1255.849% |
| HeartBeam, Inc. | 15.31 Million USD | -3468.467% |
| HeartBeam, Inc. | 15.31 Million USD | -3468.467% |
| Bullfrog AI Holdings, Inc. Warrants | 5.42 Million USD | -9968.958% |
| BrightSpring Health Services, Inc. Common Stock | 1.28 Billion USD | 57.526% |
| BrightSpring Health Services, Inc. Tangible Equity Unit | 1.28 Billion USD | 57.526% |
| CareCloud, Inc. | 93.35 Million USD | -485.36% |
| CareCloud, Inc. | 93.35 Million USD | -485.36% |
| Certara, Inc. | 254.08 Million USD | -115.072% |
| CareMax, Inc. | 670.05 Million USD | 18.443% |
| EUDA Health Holdings Limited | 4.8 Million USD | -11277.479% |
| GE HealthCare Technologies Inc. | 5.48 Billion USD | 90.041% |
| Health Catalyst, Inc. | 258.73 Million USD | -111.214% |
| Healthcare Triangle, Inc. | 18.12 Million USD | -2915.034% |
| MSP Recovery, Inc. | 565.43 Million USD | 3.352% |
| Mangoceuticals, Inc. | 9.65 Million USD | -5562.724% |
| National Research Corporation | 52.52 Million USD | -940.508% |
| Nutex Health, Inc. | 66.54 Million USD | -721.175% |
| OptimizeRx Corporation | 69.3 Million USD | -688.546% |
| R1 RCM Inc. | 336.6 Million USD | -62.351% |
| Renalytix Plc | 29.04 Million USD | -1781.736% |
| Sharecare, Inc. | 225.97 Million USD | -141.831% |
| Sharecare, Inc. | 225.97 Million USD | -141.831% |
| SHL Telemedicine Ltd. | 34.26 Million USD | -1494.756% |
| Spok Holdings, Inc. | 90.97 Million USD | -500.661% |
| Streamline Health Solutions, Inc. | 31.19 Million USD | -1652.084% |
| TruBridge, Inc. | 206.17 Million USD | -165.059% |
| 10x Genomics, Inc. | 674.94 Million USD | 19.035% |
| Zhongchao Inc. | 13.92 Million USD | -3825.128% |